Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca and Innate Pharma announce global co-development and commercialisation collaboration for IPH2201 in immuno-oncology
-
AstraZeneca enters strategic immuno-oncology collaboration with Celgene Corporation to develop PD-L1 inhibitor programme for patients with serious blood cancers
-
AstraZeneca PLC first quarter results 2015
-
AstraZeneca and Bina collaborate to deploy genomic management solution in R&D
-
Selumetinib granted Orphan Drug Designation by US FDA for treatment of uveal melanoma
-
AstraZeneca announces updated progression free survival data for investigational non-small cell lung cancer medicine AZD9291
-
Medimmune and Immunocore announce new collaboration to conduct immuno-oncology combination trials in melanoma
-
Tremelimumab granted Orphan Drug Designation by US FDA for treatment of malignant mesothelioma
-
FDA Advisory Committee reviews SAVOR outcomes study results for ONGLYZA® (saxagliptin) and KOMBIGLYZE® XR (saxagliptin and metformin HCI extended-release)
-
AstraZeneca to showcase strong oncology science at American Association for Cancer Research Annual Meeting 2015
Latest articles and press releases
All of our latest press releases and articles are available to explore
